US Biomax - Multiple Organs Tumor And Normal Tissue Array, With TNM, Clinical Stage And Pathology Grade, 250 Cases/250 Cores

Multiple Organ Sub-types (168)

Paraffin Embedded Tissue Array Types [view all]

Human

MC2501

Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases/250 cores

Unstained: $565.00

Trial (MC2501t*): $185.00

H&E (MC2501s*): $565.00

Microarray Panel:	Multiple organs tumor and normal tissue microarray, containing 40 cases of each lung non-small cell carcinoma, prostate adenocarcinoma, breast invasive ductal carcinoma, colon adenocarcinoma and pancreas duct adenocarcinoma, 10 normal tissue of each lung, prostate, colon and pancreas, 7 normal tissue of breast, 3 adjacent normal tissue of breast, single core per case
Cores:	250
Cases:	250
Layout:	25 cols × 10 rows
Core Diameter:	1 mm
Thickness:	5 µm
Quality Control:	Anti-Actin confirmed
Applications:	Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:	Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

Unstained: unstained paraffin tissue microarray slide.
Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

Slide Label: US Biomax, Inc. Tissue Array

	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16	17	18	19	20	21	22	23	24	25
A
B
C
D
E
F
G
H
I
J

Legend:

Bre - Breast, Col - Colon, Lun - Lung, Pan - Pancreas, Pro - Prostate

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage IV), - NAT, - Normal tissue

Specification Sheet

Pos	No.	Sex	Age	Organ	Pathology diagnosis	Grade	Stage	TNM	Type †
A1	1	M	60	Lung	Large cell carcinoma	–	I	T2N0M0	Malignant
A2	2	M	70	Lung	Large cell carcinoma with necrosis	–	I	T2N0M0	Malignant
A3	3	M	72	Lung	Bronchioalveolar carcinoma	–	I	T1N0M0	Malignant
A4	4	F	64	Lung	Bronchioalveolar carcinoma (chronic inflammation of fibrous tissue)	–	I	T2N0M0	Malignant
A5	5	M	62	Lung	Bronchioalveolar carcinoma	–	I	T1N0M0	Malignant
A6	6	M	54	Prostate	Adenocarcinoma (gleason grade:1, score:1+2)	1	III	T3N0M0	Malignant
A7	7	M	76	Prostate	Adenocarcinoma (gleason grade:4, score:4+5)	3	II	T2aN0M0	Malignant
A8	8	M	70	Prostate	Adenocarcinoma (hyperplasia)	–	I	T1N0M0	Malignant
A9	9	M	63	Prostate	Adenocarcinoma (gleason grade:4, score:4+5)	3	IV	T2N1M1b	Malignant
A10	10	M	72	Prostate	Adenocarcinoma (prostate tissue)	–	II	T2aN0M0	Malignant
A11	11	F	55	Breast	Invasive ductal carcinoma (fibrous tissue and blood vessel)	–	IIIb	T4N1M0	Malignant
A12	12	F	48	Breast	Invasive ductal carcinoma	2	IIa	T2N0M0	Malignant
A13	13	F	64	Breast	Invasive ductal carcinoma	2	IIa	T2N0M0	Malignant
A14	14	F	70	Breast	Invasive ductal carcinoma	3	IV	T4N2M1	Malignant
A15	15	F	41	Breast	Invasive ductal carcinoma	3	IIIa	T3N1M0	Malignant
A16	16	M	68	Colon	Adenocarcinoma	1	I	T2N0M0	Malignant
A17	17	F	51	Colon	Adenocarcinoma	3	II	T4N0M0	Malignant
A18	18	M	48	Colon	Adenocarcinoma	2	II	T3N0M0	Malignant
A19	19	M	64	Colon	Adenocarcinoma	2	II	T4N0M0	Malignant
A20	20	F	67	Colon	Adenocarcinoma	2	II	T3N0M0	Malignant
A21	21	F	46	Pancreas	Duct adenocarcinoma (sparse)	–	II	T3N0M0	Malignant
A22	22	M	77	Pancreas	Duct adenocarcinoma	1	I	T2N0M0	Malignant
A23	23	F	48	Pancreas	Duct adenocarcinoma (sparse)	2	II	T3N0M0	Malignant
A24	24	F	50	Pancreas	Duct adenocarcinoma	2	I	T2N0M0	Malignant
A25	25	M	60	Pancreas	Duct adenocarcinoma	2	II	T3N0M0	Malignant
B1	26	M	70	Lung	Papillary adenocarcinoma	1	I	T2N0M0	Malignant
B2	27	M	65	Lung	Adenocarcinoma	1	I	T1N0M0	Malignant
B3	28	M	61	Lung	Mucinous adenocarcinoma	2	II	T2N1M0	Malignant
B4	29	F	46	Lung	Adenocarcinoma	2	I	T2N0M0	Malignant
B5	30	F	50	Lung	Adenocarcinoma	2	I	T2N0M0	Malignant
B6	31	M	76	Prostate	Adenocarcinoma (gleason grade:2, score:2+3)	2	II	T2aN0M0	Malignant
B7	32	M	66	Prostate	Adenocarcinoma (gleason grade:2, score:2+2)	2	IV	31N1M1	Malignant
B8	33	M	70	Prostate	Adenocarcinoma (smooth muscle)	–	II	T2N0M0	Malignant
B9	34	M	64	Prostate	Adenocarcinoma (gleason grade:2, score:2+3)	1–2	I	T1N0M0	Malignant
B10	35	M	62	Prostate	Adenocarcinoma (gleason grade:2, score:2+4)	1–2	IV	T3N1M1b	Malignant
B11	36	F	42	Breast	Invasive ductal carcinoma	2–3	IIa	T2N0M0	Malignant
B12	37	F	62	Breast	Invasive ductal carcinoma	2	IIa	T2N0M0	Malignant
B13	38	F	39	Breast	Invasive ductal carcinoma (sparse)	2	IIa	T2N0M0	Malignant
B14	39	F	66	Breast	Invasive ductal carcinoma	2	IIb	T3N0M0	Malignant
B15	40	F	48	Breast	Invasive ductal carcinoma	2	IIa	T2N0M0	Malignant
B16	41	F	49	Colon	Adenocarcinoma	3	I	T2N0M0	Malignant
B17	42	F	63	Colon	Adenocarcinoma	2	I	T2N0M0	Malignant
B18	43	M	41	Colon	Adenocarcinoma	3	II	T4N0M0	Malignant
B19	44	F	64	Colon	Adenocarcinoma	3	II	T3N0M0	Malignant
B20	45	F	41	Colon	Adenocarcinoma	1	II	T3N1M0	Malignant
B21	46	F	54	Pancreas	Duct adenocarcinoma	2	II	T3N0M0	Malignant
B22	47	M	52	Pancreas	Duct adenocarcinoma	2	I	T2N0M0	Malignant
B23	48	M	31	Pancreas	Duct adenocarcinoma (sparse)	–	II	T3N0M0	Malignant
B24	49	F	51	Pancreas	Duct adenocarcinoma	1	IV	T4N0M0	Malignant
B25	50	M	61	Pancreas	Duct adenocarcinoma (sparse)	–	I	T2N0M0	Malignant
C1	51	F	56	Lung	Adenocarcinoma	2	I	T2N0M0	Malignant
C2	52	M	58	Lung	Adenocarcinoma	2	II	T2N1M0	Malignant
C3	53	M	47	Lung	Adenocarcinoma	2	I	T1N0M0	Malignant
C4	54	M	70	Lung	Adenocarcinoma (sparse)	–	I	T2N0M0	Malignant
C5	55	M	55	Lung	Adenocarcinoma	2	I	T2N0M0	Malignant
C6	56	M	80	Prostate	Adenocarcinoma (gleason grade:2, score:4+2)	2	IV	T4N1M1c	Malignant
C7	57	M	70	Prostate	Adenocarcinoma (gleason grade:2, score:2+3)	2	IV	T2N1M1c	Malignant
C8	58	M	65	Prostate	Adenocarcinoma (gleason grade:3, score:3+2)	2	II	T2N0M0	Malignant
C9	59	M	65	Prostate	Adenocarcinoma (gleason grade:2, score:2+3)	2	II	T2N0M0	Malignant
C10	60	M	69	Prostate	Adenocarcinoma (gleason grade:2, score:2+3)	2–3	III	T3N0M0	Malignant
C11	61	F	56	Breast	Invasive ductal carcinoma	2	I	T1N0M0	Malignant
C12	62	F	77	Breast	Invasive ductal carcinoma	2	IIa	T2N0M0	Malignant
C13	63	F	41	Breast	Invasive ductal carcinoma (fibrofatty tissue and blood vessel)	–	IIa	T2N0M0	Malignant
C14	64	F	54	Breast	Invasive ductal carcinoma	3	IIb	T3N0M0	Malignant
C15	65	F	43	Breast	Invasive ductal carcinoma	3	IIa	T2N0M0	Malignant
C16	66	M	31	Colon	Adenocarcinoma	2	II	T4N0M0	Malignant
C17	67	M	61	Colon	Adenocarcinoma	2	II	T3N1M0	Malignant
C18	68	M	62	Colon	Adenocarcinoma	2	I	T3N0M0	Malignant
C19	69	F	62	Colon	Adenocarcinoma (sparse) with necrosis	–	II	T4N0M0	Malignant
C20	70	M	57	Colon	Mucinous adenocarcinoma	2	II	T3N1M0	Malignant
C21	71	F	72	Pancreas	Duct adenocarcinoma	2	II	T4N0M0	Malignant
C22	72	M	52	Pancreas	Duct adenocarcinoma	2	III	T3N1M0	Malignant
C23	73	F	43	Pancreas	Duct adenocarcinoma	2	II	T3N0M0	Malignant
C24	74	M	59	Pancreas	Duct adenocarcinoma	2	II	T3N0M0	Malignant
C25	75	M	49	Pancreas	Duct adenocarcinoma	2	I	T2N0M0	Malignant
D1	76	M	60	Lung	Papillary adenocarcinoma	2	I	T2N0M0	Malignant
D2	77	M	62	Lung	Papillary adenocarcinoma	2	I	T2N0M0	Malignant
D3	78	F	57	Lung	Adenocarcinoma	2	I	T2N0M0	Malignant
D4	79	F	45	Lung	Adenocarcinoma	2	I	T2N0M0	Malignant
D5	80	M	65	Lung	Adenocarcinoma	3	I	T2N0M0	Malignant
D6	81	M	64	Prostate	Adenocarcinoma (gleason grade:2, score:2+3)	2	IV	T3N0M1	Malignant
D7	82	M	82	Prostate	Adenocarcinoma (gleason grade:4, score:4+5)	3	IV	T3N2M1c	Malignant
D8	83	M	73	Prostate	Adenocarcinoma (cataplasia and necrotic tissue)	–	II	T2N0M0	Malignant
D9	84	M	61	Prostate	Adenocarcinoma (gleason grade:2, score:2+3)	2	III	T3N1M0	Malignant
D10	85	M	64	Prostate	Adenocarcinoma (gleason grade:3, score:3+4)	2–3	II	T2aN0M0	Malignant
D11	86	F	46	Breast	Invasive ductal carcinoma	3	IIa	T2N0M0	Malignant
D12	87	F	50	Breast	Invasive ductal carcinoma	3	I	T1N0M0	Malignant
D13	88	F	55	Breast	Invasive ductal carcinoma (sparse)	–	I	T1N0M0	Malignant
D14	89	F	50	Breast	Invasive ductal carcinoma	3	IIIb	T4N1M0	Malignant
D15	90	F	62	Breast	Invasive ductal carcinoma	2	I	T1N0M0	Malignant
D16	91	M	73	Colon	Adenocarcinoma	2	II	T4N0M0	Malignant
D17	92	M	53	Colon	Adenocarcinoma	2	II	T4N0M0	Malignant
D18	93	F	74	Colon	Adenocarcinoma	2	II	T4N0M0	Malignant
D19	94	M	55	Colon	Adenocarcinoma	2	II	T4N0M0	Malignant
D20	95	F	79	Colon	Adenocarcinoma	2	II	T4N0M0	Malignant
D21	96	M	65	Pancreas	Duct adenocarcinoma (sparse)	–	II	T3N0M0	Malignant
D22	97	M	50	Pancreas	Duct adenocarcinoma (sparse)	3	III	T2N1M0	Malignant
D23	98	M	55	Pancreas	Duct adenocarcinoma	2	II	T3N0M0	Malignant
D24	99	M	44	Pancreas	Duct adenocarcinoma	2–3	II	T3N0M0	Malignant
D25	100	M	52	Pancreas	Duct adenocarcinoma	2	I	T1N0M0	Malignant
E1	101	M	61	Lung	Adenocarcinoma	3	I	T1N0M0	Malignant
E2	102	F	54	Lung	Adenocarcinoma	3	IIIa	T3N0M0	Malignant
E3	103	M	60	Lung	Squamous cell carcinoma	1	I	T2N0M0	Malignant
E4	104	M	51	Lung	Squamous cell carcinoma with necrosis	1	I	T2N0M0	Malignant
E5	105	M	76	Lung	Squamous cell carcinoma	1	II	T2N1M0	Malignant
E6	106	M	60	Prostate	Adenocarcinoma (gleason grade:2, score:2+2)	2	IV	T4N1M1c	Malignant
E7	107	M	20	Prostate	Adenocarcinoma (gleason grade:3, score:3+4)	2	III	T3N0M0	Malignant
E8	108	M	75	Prostate	Adenocarcinoma (sparse)	–	IV	T2N1M1c	Malignant
E9	109	M	70	Prostate	Adenocarcinoma (sparse)	–	III	T3N0M0	Malignant
E10	110	M	64	Prostate	Adenocarcinoma (gleason grade:3, score:3+4)	2–3	II	T2N0M0	Malignant
E11	111	F	42	Breast	Invasive ductal carcinoma	2	IIa	T2N0M0	Malignant
E12	112	F	50	Breast	Invasive ductal carcinoma	3	IIa	T2N0M0	Malignant
E13	113	F	47	Breast	Invasive ductal carcinoma	2	IIa	T2N0M0	Malignant
E14	114	F	47	Breast	Invasive ductal carcinoma	2	I	T1N0M0	Malignant
E15	115	F	53	Breast	Invasive ductal carcinoma	3	IIa	T2N0M0	Malignant
E16	116	F	54	Colon	Adenocarcinoma (sparse)	–	II	T4N0M0	Malignant
E17	117	F	58	Colon	Adenocarcinoma	2	II	T4N0M0	Malignant
E18	118	M	66	Colon	Adenocarcinoma (sparse) with necrosis	–	II	T4N0M0	Malignant
E19	119	M	46	Colon	Adenocarcinoma	2	II	T4N0M0	Malignant
E20	120	F	78	Colon	Adenocarcinoma	2	II	T4N0M0	Malignant
E21	121	F	72	Pancreas	Duct adenocarcinoma	2	II	T3N0M0	Malignant
E22	122	F	75	Pancreas	Duct adenocarcinoma (sparse)	–	IV	T3N0M1	Malignant
E23	123	F	67	Pancreas	Duct adenocarcinoma (sparse)	3	II	T3N0M0	Malignant
E24	124	M	60	Pancreas	Duct adenocarcinoma (chronic inflammation of pancreatic duct)	–	I	T2N0M0	Malignant
E25	125	F	68	Pancreas	Duct adenocarcinoma	2	II	T3N0M0	Malignant
F1	126	M	55	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
F2	127	M	66	Lung	Squamous cell carcinoma	1	I	T2N0M0	Malignant
F3	128	M	69	Lung	Squamous cell carcinoma	3	I	T1N0M0	Malignant
F4	129	M	70	Lung	Squamous cell carcinoma	1	I	T2N0M0	Malignant
F5	130	M	55	Lung	Squamous cell carcinoma (necrotic tissue)	–	I	T2N0M0	Malignant
F6	131	M	78	Prostate	Adenocarcinoma (gleason grade:5, score:2+3)	3	IV	T4N1M1b	Malignant
F7	132	M	72	Prostate	Adenocarcinoma (gleason grade:4, score:4+5)	3	III	T3N0M0	Malignant
F8	133	M	81	Prostate	Adenocarcinoma (gleason grade:4, score:4+4)	2–3	III	T3N0M0	Malignant
F9	134	M	65	Prostate	Adenocarcinoma (gleason grade:4, score:4+5)	3	IV	T2N1M1	Malignant
F10	135	M	75	Prostate	Adenocarcinoma (gleason grade:4, score:4+5)	3	IV	T3N0M1b	Malignant
F11	136	F	44	Breast	Invasive ductal carcinoma	3	IIa	T2N0M0	Malignant
F12	137	F	40	Breast	Invasive ductal carcinoma	3	IIb	T2N1M0	Malignant
F13	138	F	51	Breast	Invasive ductal carcinoma (fibrous tissue and blood vessel)	–	IIIb	T4N0M0	Malignant
F14	139	F	40	Breast	Invasive ductal carcinoma	3	IIa	T2N0M0	Malignant
F15	140	F	49	Breast	Invasive ductal carcinoma	3	IIa	T2N0M0	Malignant
F16	141	M	57	Colon	Adenocarcinoma	2	II	T4N0M0	Malignant
F17	142	F	57	Colon	Adenocarcinoma	2–3	I	T2N0M0	Malignant
F18	143	F	52	Colon	Adenocarcinoma	2	II	T3N1M0	Malignant
F19	144	M	38	Colon	Adenocarcinoma	2	IV	T4N1M0	Malignant
F20	145	F	58	Colon	Adenocarcinoma	2	II	T3N1M0	Malignant
F21	146	M	60	Pancreas	Duct adenocarcinoma	2	II	T3N0M0	Malignant
F22	147	F	51	Pancreas	Duct adenocarcinoma	2	II	T3N0M0	Malignant
F23	148	F	23	Pancreas	Duct adenocarcinoma (sparse) with necrosis	3	I	T2N0M0	Malignant
F24	149	M	56	Pancreas	Duct adenocarcinoma (sparse) with necrosis	3	III	T2N1bM0	Malignant
F25	150	F	46	Pancreas	Duct adenocarcinoma	2	II	T4N0M0	Malignant
G1	151	M	73	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
G2	152	M	66	Lung	Squamous cell carcinoma	1	I	T2N0M0	Malignant
G3	153	M	56	Lung	Squamous cell carcinoma (hyperplasia of alveolar epithelium)	–	I	T1N0M0	Malignant
G4	154	M	54	Lung	Squamous cell carcinoma	2	IIIb	T2N3M0	Malignant
G5	155	M	48	Lung	Squamous cell carcinoma	2	I	T2N0M0	Malignant
G6	156	M	51	Prostate	Adenocarcinoma (gleason grade:3, score:3+5)	2	II	T2N0M0	Malignant
G7	157	M	69	Prostate	Adenocarcinoma (gleason grade:4, score:4+5)	3	II	T2N0M0	Malignant
G8	158	M	56	Prostate	Adenocarcinoma (gleason grade:5, score:5+5)	3	II	T2N0M0	Malignant
G9	159	M	75	Prostate	Adenocarcinoma (gleason grade:5, score:5+4)	3	II	T2N0M0	Malignant
G10	160	M	74	Prostate	Adenocarcinoma (gleason grade:4, score:4+5)	2–3	IV	T4N1M1c	Malignant
G11	161	F	52	Breast	Invasive ductal carcinoma	3	IIIb	T4cN2M0	Malignant
G12	162	F	63	Breast	Invasive ductal carcinoma	3	IIa	T2N0M0	Malignant
G13	163	F	49	Breast	Invasive ductal carcinoma	3	IIIb	T4N0M0	Malignant
G14	164	F	60	Breast	Invasive ductal carcinoma (sparse)	3	IIIb	T4N0M0	Malignant
G15	165	F	68	Breast	Invasive ductal carcinoma	2	IIa	T2N0M0	Malignant
G16	166	M	72	Colon	Adenocarcinoma	3	II	T4N0M0	Malignant
G17	167	M	35	Colon	Adenocarcinoma	3	II	T4N0M0	Malignant
G18	168	M	70	Colon	Mucinous adenocarcinoma	1	II	T4N0M0	Malignant
G19	169	F	48	Colon	Adenocarcinoma	3	IV	T4N2M1	Malignant
G20	170	F	34	Colon	Adenocarcinoma	3	II	T4N0M0	Malignant
G21	171	M	61	Pancreas	Duct adenocarcinoma	3	IV	T3N0M1	Malignant
G22	172	M	41	Pancreas	Duct adenocarcinoma	3	III	T4N1M0	Malignant
G23	173	M	62	Pancreas	Duct adenocarcinoma (sparse)	3	III	T3N1M0	Malignant
G24	174	F	57	Pancreas	Duct adenocarcinoma	3	I	T2N0M0	Malignant
G25	175	M	59	Pancreas	Duct adenocarcinoma (fibrofatty tissue and blood vessel)	–	II	T3N0M0	Malignant
H1	176	M	65	Lung	Squamous cell carcinoma	2	IIIa	T3N0M0	Malignant
H2	177	M	61	Lung	Squamous cell carcinoma	2–3	I	T2N0M0	Malignant
H3	178	M	52	Lung	Squamous cell carcinoma	3	I	T2N0M0	Malignant
H4	179	M	53	Lung	Squamous cell carcinoma	3	I	T1N0M0	Malignant
H5	180	M	65	Lung	Squamous cell carcinoma	3	II	T2N1M0	Malignant
H6	181	M	62	Prostate	Adenocarcinoma (gleason grade:5, score:5+5)	3	II	T2N0M0	Malignant
H7	182	M	76	Prostate	Adenocarcinoma (prostate tissue)	–	IV	T3N1M1b	Malignant
H8	183	M	73	Prostate	Adenocarcinoma (gleason grade:5, score:5+5)	3	IV	T4N1M1c	Malignant
H9	184	M	60	Prostate	Adenocarcinoma (gleason grade:4, score:4+5)	3	IV	T3N1M1b	Malignant
H10	185	M	77	Prostate	Adenocarcinoma (gleason grade:4, score:4+5)	3	II	T2N0M0	Malignant
H11	186	F	50	Breast	Invasive ductal carcinoma	3	II	T2N0M0	Malignant
H12	187	F	48	Breast	Invasive ductal carcinoma	3	I	T1N0M0	Malignant
H13	188	F	50	Breast	Invasive ductal carcinoma	2	IIIa	T3N1M0	Malignant
H14	189	F	54	Breast	Invasive ductal carcinoma	3	II	T2N0M0	Malignant
H15	190	F	38	Breast	Invasive ductal carcinoma (tumoral necrosis)	–	II	T2N0M0	Malignant
H16	191	M	71	Colon	Signet-ring cell carcinoma	–	II	T4N0M0	Malignant
H17	192	M	64	Colon	Adenocarcinoma	3	II	T3N0M0	Malignant
H18	193	M	65	Colon	Adenocarcinoma	3	II	T3N1M0	Malignant
H19	194	M	46	Colon	Adenocarcinoma	3	II	T4N0M0	Malignant
H20	195	M	37	Colon	Adenocarcinoma	3	II	T4N0M0	Malignant
H21	196	F	53	Pancreas	Duct adenocarcinoma	2–3	II	T3N0M0	Malignant
H22	197	M	50	Pancreas	Duct adenocarcinoma	3	I	T2N0M0	Malignant
H23	198	F	48	Pancreas	Duct adenocarcinoma	3	II	T3N0M0	Malignant
H24	199	F	60	Pancreas	Duct adenocarcinoma (sparse)	3	II	T4N0M0	Malignant
H25	200	M	55	Pancreas	Duct adenocarcinoma	3	II	T3N0M0	Malignant
I1	201	M	49	Lung	Normal lung tissue	–	–	–	Normal
I2	202	M	42	Lung	Normal lung tissue	–	–	–	Normal
I3	203	M	55	Lung	Normal lung tissue	–	–	–	Normal
I4	204	F	21	Lung	Normal lung tissue	–	–	–	Normal
I5	205	M	50	Lung	Normal lung tissue	–	–	–	Normal
I6	206	M	37	Prostate	Normal prostatic tissue	–	–	–	Normal
I7	207	M	45	Prostate	Normal prostatic tissue	–	–	–	Normal
I8	208	M	35	Prostate	Normal prostatic tissue	–	–	–	Normal
I9	209	M	40	Prostate	Normal prostatic tissue	–	–	–	Normal
I10	210	M	40	Prostate	Normal prostatic tissue	–	–	–	Normal
I11	211	F	15	Breast	Normal breast tissue (fibrofatty tissue)	–	–	–	Normal
I12	212	F	21	Breast	Normal breast tissue (fibrous tissue and blood vessel)	–	–	–	Normal
I13	213	F	35	Breast	Normal breast tissue (fibrous tissue and blood vessel)	–	–	–	Normal
I14	214	F	19	Breast	Normal breast tissue (fibrofatty tissue)	–	–	–	Normal
I15	215	F	42	Breast	Normal breast tissue (fibrofatty tissue and blood vessel)	–	–	–	Normal
I16	216	M	28	Colon	Normal colonic tissue	–	–	–	Normal
I17	217	M	45	Colon	Normal colonic tissue (fibrous tissue)	–	–	–	Normal
I18	218	M	35	Colon	Normal colonic mucosa tissue	–	–	–	Normal
I19	219	F	21	Colon	Normal colonic tissue	–	–	–	Normal
I20	220	M	30	Colon	Normal colonic mucosa tissue	–	–	–	Normal
I21	221	F	38	Pancreas	Normal pancreatic tissue	–	–	–	Normal
I22	222	F	35	Pancreas	Normal pancreatic tissue	–	–	–	Normal
I23	223	M	5 Mon.	Pancreas	Normal pancreatic tissue	–	–	–	Normal
I24	224	M	38	Pancreas	Normal pancreatic tissue	–	–	–	Normal
I25	225	M	40	Pancreas	Normal pancreatic tissue	–	–	–	Normal
J1	226	M	22	Lung	Normal lung tissue	–	–	–	Normal
J2	227	M	35	Lung	Normal lung tissue	–	–	–	Normal
J3	228	M	19	Lung	Normal lung tissue	–	–	–	Normal
J4	229	F	41	Lung	Normal lung tissue	–	–	–	Normal
J5	230	M	48	Lung	Normal lung tissue	–	–	–	Normal
J6	231	M	30	Prostate	Normal prostatic tissue	–	–	–	Normal
J7	232	M	43	Prostate	Normal prostatic tissue (sparse)	–	–	–	Normal
J8	233	M	35	Prostate	Normal prostatic tissue	–	–	–	Normal
J9	234	M	28	Prostate	Normal prostatic tissue	–	–	–	Normal
J10	235	M	33	Prostate	Normal prostatic tissue (sparse)	–	–	–	Normal
J11	236	F	50	Breast	Normal breast tissue (hyperplasia of duct)	–	–	–	Normal
J12	237	F	18	Breast	Normal breast tissue (fibrofatty tissue and blood vessel)	–	–	–	Normal
J13	238	F	35	Breast	Cancer adjacent normal breast tissue (fibrous tissue and blood vessel)	–	–	–	NAT
J14	239	F	53	Breast	Cancer adjacent normal breast tissue (fibrous tissue and blood vessel)	–	–	–	NAT
J15	240	F	40	Breast	Cancer adjacent normal breast tissue	–	–	–	NAT
J16	241	M	35	Colon	Normal colonic tissue (fibrous tissue, blood vessel and smooth muscle)	–	–	–	Normal
J17	242	M	33	Colon	Normal colonic tissue	–	–	–	Normal
J18	243	M	25	Colon	Normal colonic tissue	–	–	–	Normal
J19	244	M	35	Colon	Normal colonic tissue (sparse)	–	–	–	Normal
J20	245	M	30	Colon	Normal colonic tissue (sparse)	–	–	–	Normal
J21	246	M	30	Pancreas	Normal pancreatic tissue	–	–	–	Normal
J22	247	M	40	Pancreas	Normal pancreatic tissue (fatty tissue)	–	–	–	Normal
J23	248	M	47	Pancreas	Normal pancreatic tissue	–	–	–	Normal
J24	249	M	50	Pancreas	Normal pancreatic tissue	–	–	–	Normal
J25	250	M	25	Pancreas	Normal pancreatic tissue	–	–	–	Normal
–	–	M	58	Skin	Malignant melanoma (tissue marker)	–			Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:

Paraffin Embedded Tissue Array Types [view all]

Human

Cell Arrays (2)

Mouse (16)

Rat (9)

Monkey (5)

Frozen Tissue Arrays (54)

MC2501

*Tissue Microarray Slide Types:

Microarray Panel Display

Specification Sheet

TNM grading: